MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 167 filers reported holding MERIDIAN BIOSCIENCE INC in Q1 2017. The put-call ratio across all filers is 1.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $1,194,000 | -8.5% | 67,447 | -0.3% | 0.46% | -8.8% |
Q3 2016 | $1,305,000 | +19.7% | 67,672 | +21.0% | 0.51% | +14.3% |
Q2 2016 | $1,090,000 | +3.3% | 55,922 | +9.3% | 0.45% | +0.9% |
Q1 2016 | $1,055,000 | -3.0% | 51,172 | -3.5% | 0.44% | -16.1% |
Q4 2015 | $1,088,000 | +22.4% | 53,012 | +1.9% | 0.53% | +15.3% |
Q3 2015 | $889,000 | -5.2% | 52,012 | +3.3% | 0.46% | +1.6% |
Q2 2015 | $938,000 | +1.6% | 50,342 | +4.1% | 0.45% | +2.5% |
Q1 2015 | $923,000 | +16.4% | 48,352 | +0.3% | 0.44% | +4.8% |
Q4 2014 | $793,000 | -3.4% | 48,202 | +3.9% | 0.42% | -13.4% |
Q3 2014 | $821,000 | -8.0% | 46,402 | +7.4% | 0.48% | -8.5% |
Q2 2014 | $892,000 | +9.6% | 43,222 | +15.8% | 0.53% | +6.2% |
Q1 2014 | $814,000 | +0.4% | 37,337 | +22.1% | 0.50% | -7.9% |
Q4 2013 | $811,000 | – | 30,572 | – | 0.54% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Euclidean Technologies Management, LLC | 115,571 | $3,034,000 | 2.64% |
Acuitas Investments, LLC | 160,046 | $4,201,000 | 2.41% |
HUSSMAN STRATEGIC ADVISORS, INC. | 144,000 | $3,780,000 | 0.78% |
GLOBEFLEX CAPITAL L P | 158,664 | $4,165,000 | 0.76% |
CLARK ESTATES INC/NY | 220,000 | $5,775,000 | 0.74% |
SYSTEMATIC FINANCIAL MANAGEMENT LP | 721,176 | $18,931,000 | 0.69% |
EARNEST PARTNERS LLC | 4,341,834 | $113,973,000 | 0.68% |
MOODY ALDRICH PARTNERS LLC | 138,844 | $3,645,000 | 0.53% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 889,269 | $23,343,000 | 0.49% |
Phocas Financial Corp. | 134,740 | $3,537,000 | 0.47% |